Zintars G. Beldavs

11.9k citations

39 papers · 7.5k indexed · 3 hit papers · h-index 19

Infectious Diseases top 0.1%
Epidemiology top 0.5%
Critical Care and Intensive Care Medicine top 0.1%
Surgery top 2%
Molecular Biology top 10%

Co-authors: Ghinwa Dumyati Lucy Wilson Scott K. Fridkin Wendy Bamberg Marion Kainer Jonathan R. Edwards Ruth Lynfield Joelle Nadle
Topics: Clostridium difficile and Clostridium perfringens research (20 papers)Nosocomial Infections in ICU (16 papers)Microscopic Colitis (16 papers)
Cited by: Applied Microbiology and Biotechnology Critical Care and Intensive Care Medicine Infectious Diseases
Journals: New England Journal of Medicine JAMA PLoS ONE
Partner nations: United States Uganda Germany

In The Last Decade

Zintars G. Beldavs

39 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multistate Point-Prevalence Survey of Health Care–Associated Infections

2014 2.9k citations Shelley S. Magill, Jonathan R. Edwards et al. New England Journal of Medicine profile →
Burden of Clostridium difficile Infection in the United States

2015 2.0k citations Fernanda C. Lessa, Yi Mu et al. New England Journal of Medicine profile →
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes

2020 529 citations Alice Guh, Yi Mu et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Zintars G. Beldavs

Since Specialization

Citations

This map shows the geographic impact of Zintars G. Beldavs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zintars G. Beldavs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zintars G. Beldavs more than expected).

Fields of papers citing papers by Zintars G. Beldavs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zintars G. Beldavs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zintars G. Beldavs. The network helps show where Zintars G. Beldavs may publish in the future.

Co-authorship network of co-authors of Zintars G. Beldavs

This figure shows the co-authorship network connecting the top 25 collaborators of Zintars G. Beldavs. A scholar is included among the top collaborators of Zintars G. Beldavs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zintars G. Beldavs. Zintars G. Beldavs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of viral co-infections among patients with community-associated Clostridioides difficile infection 2020 ·PLoS ONE ·(unknown),Jessica Cohen,Nicole Gregoricus,Monica M. Farley,Rebecca Perlmutter,Stacy Holzbauer,Ghinwa Dumyati,Zintars G. Beldavs,Ashley Paulick,Jan Vinjé,Brandi Limbago,Fernanda C. Lessa,Alice Guh	2
2	Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013–2015 2019 ·Journal of General Internal Medicine ·Shannon Novosad,Yi Mu,Lisa G. Winston,Helen Johnston,(unknown),Danyel Olson,Monica M. Farley,(unknown),Lucy Wilson,Rebecca Perlmutter,Stacy Holzbauer,(unknown),Erin C. Phipps,Ghinwa Dumyati,Zintars G. Beldavs,Valerie Ocampo,(unknown),Marion Kainer,Dale N. Gerding,Alice Guh	4
3	Risk factors for community-associated Clostridioides difficile infection in young children 2019 ·Epidemiology and Infection ·Min Weng,Susan Hocevar Adkins,Wendy Bamberg,Monica M. Farley,(unknown),Lucy Wilson,Rebecca Perlmutter,Stacy Holzbauer,(unknown),Erin C. Phipps,Emily Hancock,Ghinwa Dumyati,Deborah Nelson,Zintars G. Beldavs,Valerie Ocampo,(unknown),(unknown),(unknown),L. Clifford McDonald,Alice Guh	14
4	Compliance with statewide regulations for communication of patients’ multidrug-resistant organism and Clostridium difficile status during transitions of care 2019 ·American Journal of Infection Control ·Katherine Ellingson,Brie N. Noble,Dat Tran,Genevieve L. Buser,Christopher D. Pfeiffer,P. Maureen Cassidy,Rebecca Pierce,Zintars G. Beldavs,Jon P. Furuno	2
5	Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015 2018 ·American Journal of Infection Control ·Alice Guh,Yi Mu,James Baggs,Lisa G. Winston,Wendy Bamberg,Carol Lyons,Monica M. Farley,Lucy Wilson,Stacy Holzbauer,Erin C. Phipps,Zintars G. Beldavs,Marion Kainer,Maria Karlsson,Dale N. Gerding,Ghinwa Dumyati	17
6	Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011 2017 ·Open Forum Infectious Diseases ·Shelley S. Magill,Lucy Wilson,Deborah Thompson,Susan M. Ray,Joelle Nadle,Ruth Lynfield,Sarah J. Janelle,Marion Kainer,Samantha Greissman,Ghinwa Dumyati,Zintars G. Beldavs,Jonathan R. Edwards	3
7	Failure to Communicate: Transmission of Extensively Drug-Resistantbla_OXA-237-ContainingAcinetobacter baumannii—Multiple Facilities in Oregon, 2012–2014 2017 ·Infection Control and Hospital Epidemiology ·Genevieve L. Buser,P. Maureen Cassidy,Margaret C. Cunningham,Susan D. Rudin,Andrea M. Hujer,(unknown),Jon P. Furuno,Steven H. Marshall,Paul G. Higgins,Michael R. Jacobs,Meredith S. Wright,Mark D. Adams,Robert A. Bonomo,Christopher D. Pfeiffer,Zintars G. Beldavs	15
8	Risk Factors for Community-Associated Clostridium difficile Infection in Children 2017 ·Open Forum Infectious Diseases ·Mark K. Weng,Susan Hocevar Adkins,Monica M. Farley,(unknown),(unknown),(unknown),Emily Hancock,Ghinwa Dumyati,(unknown),Lucy Wilson,Zintars G. Beldavs,L. Clifford McDonald,Alice Guh	1
9	Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing bla _OXA-237 Carried on a Plasmid 2017 ·Antimicrobial Agents and Chemotherapy ·Andrea M. Hujer,Paul G. Higgins,Susan D. Rudin,Genevieve L. Buser,Steven H. Marshall,Kyriaki Xanthopoulou,Harald Seifert,Laura J. Rojas,Tatiana Domitrovic,P. Maureen Cassidy,Margaret C. Cunningham,(unknown),Jon P. Furuno,Christopher D. Pfeiffer,Zintars G. Beldavs,Meredith S. Wright,Michael R. Jacobs,Mark D. Adams,Robert A. Bonomo	33
10	Prevalence of and Factors Associated with Clostridium difficile Co-infection Among Patients with Candidemia, United States, 2014–2016 2017 ·Open Forum Infectious Diseases ·Sharon Tsay,Kaitlin Benedict,Zintars G. Beldavs,Monica M. Farley,Lee H. Harrison,William Schaffner,(unknown),Tom Chiller,Snigdha Vallabhaneni	1
11	Evaluation of the Carba NP Test in Oregon, 2013 2016 ·Antimicrobial Agents and Chemotherapy ·(unknown),(unknown),P. Maureen Cassidy,Genevieve L. Buser,(unknown),(unknown),Scott J. Weissman,Zintars G. Beldavs,Christopher D. Pfeiffer	9
12	Burden of Clostridium difficile Infection in the United Statesbreakdown → 2015 ·New England Journal of Medicine ·Fernanda C. Lessa,Yi Mu,Wendy Bamberg,Zintars G. Beldavs,Ghinwa Dumyati,John R. Dunn,Monica M. Farley,Stacy Holzbauer,James Meek,Erin C. Phipps,Lucy Wilson,Lisa G. Winston,Jessica Cohen,Brandi Limbago,Scott K. Fridkin,Dale N. Gerding,L. Clifford McDonald	2007
13	NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection 2014 ·Clinical Infectious Diseases ·Isaac See,Yi Mu,Jessica Cohen,Zintars G. Beldavs,Lisa G. Winston,Ghinwa Dumyati,Stacy Holzbauer,Dori B. Reissman,Monica M. Farley,Carol A. Lyons,Helen Johnston,Erin C. Phipps,Rebecca Perlmutter,Lydia Anderson,Dale N. Gerding,Fernanda C. Lessa	135
14	Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations 2014 ·Open Forum Infectious Diseases ·Fernanda C. Lessa,Yi Mu,Lisa G. Winston,Ghinwa Dumyati,Monica M. Farley,Zintars G. Beldavs,(unknown),Stacy Holzbauer,James Meek,Jessica Cohen,L. Clifford McDonald,Scott K. Fridkin	41
15	218Changes in Antimicrobial Prescribing Patterns Following Implementation of The Oregon Antimicrobial Stewardship Collaborative (OASC) 2014 ·Open Forum Infectious Diseases ·Lynne Strasfeld,(unknown),Robert F. Arao,Zintars G. Beldavs,Katherine Ellingson,(unknown),Ann Thomas,Graeme N. Forrest	1
16	Establishment of a Statewide Network for Carbapenem-Resistant Enterobacteriaceae Prevention in a Low-Incidence Region 2014 ·Infection Control and Hospital Epidemiology ·Christopher D. Pfeiffer,Margaret C. Cunningham,Tasha Poissant,Jon P. Furuno,John M. Townes,(unknown),Ann Thomas,Genevieve L. Buser,Robert F. Arao,Zintars G. Beldavs	12
17	Evaluating the Accuracy of Sampling to Estimate Central Line–Days Simplification of the National Healthcare Safety Network Surveillance Methods 2013 ·Infection Control and Hospital Epidemiology ·Nicola D. Thompson,Jonathan R. Edwards,Wendy Bamberg,Zintars G. Beldavs,Ghinwa Dumyati,(unknown),Meghan Maloney,Marion Kainer,Susan M. Ray,Deborah Thompson,Lucy Wilson,Shelley S. Magill	14
18	Statewide Validation of Hospital-Reported Central Line–Associated Bloodstream Infections: Oregon, 2009 2012 ·Infection Control and Hospital Epidemiology ·(unknown),Margaret C. Cunningham,Zintars G. Beldavs,(unknown),Stephen W. Moore,Ann Thomas,Paul R. Cieslak	25
19	Testing the Oregon delinquency model with 9-year follow-up of the Oregon Divorce Study 2009 ·Development and Psychopathology ·Marion S. Forgatch,Gerald R. Patterson,David S. DeGarmo,Zintars G. Beldavs	159
20	An efficacious theory-based intervention for stepfamilies 2005 ·Behavior Therapy ·Marion S. Forgatch,David S. DeGarmo,Zintars G. Beldavs	64

About Zintars G. Beldavs

Zintars G. Beldavs is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 39 papers that have together received 7.5k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (20 papers), Nosocomial Infections in ICU (16 papers) and Microscopic Colitis (16 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (864 citations), Critical Care and Intensive Care Medicine (1.4k citations) and Infectious Diseases (4.7k citations). Zintars G. Beldavs has collaborated with scholars based in United States, Uganda and Germany. Frequent co-authors include Ghinwa Dumyati, Lucy Wilson, Scott K. Fridkin, Wendy Bamberg, Marion Kainer, Jonathan R. Edwards, Ruth Lynfield, Joelle Nadle, Deborah Thompson and Shelley S. Magill. Their work appears in journals such as New England Journal of Medicine, JAMA and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact